FBT vs. HLAL
FBT (First Trust Amex Biotechnology Index) and HLAL (Wahed FTSE USA Shariah ETF) are both exchange-traded funds - FBT is a Health & Biotech Equities fund tracking the NYSE Arca Biotechnology Index, while HLAL is a Large Cap Growth Equities fund tracking the FTSE Shariah USA Index. Both are passively managed. Over the past 5 years, FBT returned 5.65%/yr vs 14.79%/yr for HLAL. A 0.61 correlation means they provide meaningful diversification when combined. FBT charges 0.57%/yr vs 0.50%/yr for HLAL.
Performance
FBT vs. HLAL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FBT achieves a 9.24% return, which is significantly lower than HLAL's 14.16% return.
FBT
- 1D
- -0.71%
- 1M
- 9.05%
- YTD
- 9.24%
- 6M
- 7.98%
- 1Y
- 38.85%
- 3Y*
- 12.49%
- 5Y*
- 5.65%
- 10Y*
- 9.74%
HLAL
- 1D
- 0.43%
- 1M
- 0.86%
- YTD
- 14.16%
- 6M
- 13.95%
- 1Y
- 36.85%
- 3Y*
- 19.70%
- 5Y*
- 14.79%
- 10Y*
- —
FBT vs. HLAL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 9.24% | 24.25% | 5.88% | 2.55% | -4.83% | -2.26% | 12.96% | 8.14% |
HLAL Wahed FTSE USA Shariah ETF | 14.16% | 18.30% | 16.70% | 30.13% | -17.56% | 28.64% | 24.65% | 10.61% |
Correlation
The correlation between FBT and HLAL is 0.50, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.50 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.52 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.59 |
Correlation (All Time) Calculated using the full available price history since Jul 16, 2019 | 0.61 |
The correlation between FBT and HLAL shifts across timeframes, from 0.50 (1 year) to 0.61 (all time), reflecting how their relationship changes across market environments.
FBT vs. HLAL - Sectors Allocation Comparison
Sectors
FBT
HLAL
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
FBT
HLAL
Basic Materials
FBT
-
HLAL
Communication Services
FBT
-
HLAL
Consumer Cyclical
FBT
-
HLAL
Consumer Defensive
FBT
-
HLAL
Energy
FBT
-
HLAL
Financial Services
FBT
-
HLAL
Industrials
FBT
-
HLAL
Real Estate
FBT
-
HLAL
Technology
FBT
-
HLAL
Utilities
FBT
-
HLAL
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FBT vs. HLAL — Risk / Return Rank
FBT
HLAL
FBT vs. HLAL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Amex Biotechnology Index (FBT) and Wahed FTSE USA Shariah ETF (HLAL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FBT | HLAL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.80 | ||
| Sortino ratioReturn per unit of downside risk | -0.88 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.46 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 2.62 | 3.51 | -0.89 |
| Martin ratioReturn relative to average drawdown | 7.73 | 15.44 | -7.71 |
Loading charts...
Drawdowns
FBT vs. HLAL - Drawdown Comparison
The maximum FBT drawdown since its inception was -40.51%, which is greater than HLAL's maximum drawdown of -33.57%. Use the drawdown chart below to compare losses from any high point for FBT and HLAL.
Loading charts...
Drawdown Indicators
| FBT | HLAL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.51% | -33.57% | -6.94% |
Max Drawdown (1Y)Largest decline over 1 year | -14.26% | -10.20% | -4.06% |
Max Drawdown (3Y)Largest decline over 3 years | -20.05% | -21.67% | +1.62% |
Max Drawdown (5Y)Largest decline over 5 years | -28.98% | -23.18% | -5.80% |
Max Drawdown (10Y)Largest decline over 10 years | -32.37% | — | — |
Current DrawdownCurrent decline from peak | -0.71% | -3.91% | +3.20% |
Average DrawdownAverage peak-to-trough decline | -11.15% | -4.99% | -6.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.84% | 2.31% | +2.53% |
Volatility
FBT vs. HLAL - Volatility Comparison
First Trust Amex Biotechnology Index (FBT) has a higher volatility of 7.35% compared to Wahed FTSE USA Shariah ETF (HLAL) at 5.63%. This indicates that FBT's price experiences larger fluctuations and is considered to be riskier than HLAL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FBT | HLAL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.35% | 5.63% | +1.72% |
Volatility (6M)Calculated over the trailing 6-month period | 16.17% | 11.03% | +5.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.10% | 13.93% | +7.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.86% | 17.71% | +4.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.89% | 20.25% | +3.64% |
FBT vs. HLAL - Expense Ratio Comparison
FBT has a 0.57% expense ratio, which is higher than HLAL's 0.50% expense ratio.
Dividends
FBT vs. HLAL - Dividend Comparison
FBT has not paid dividends to shareholders, while HLAL's dividend yield for the trailing twelve months is around 0.46%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 0.00% | 0.00% | 0.71% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
HLAL Wahed FTSE USA Shariah ETF | 0.46% | 0.53% | 0.58% | 0.72% | 1.15% | 0.78% | 0.97% | 0.72% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
FBT and HLAL have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FBT has higher volatility (7.35%) compared to HLAL (5.63%). In terms of maximum drawdown, FBT dropped -40.51% vs HLAL's -33.57%.
On 5-year performance, HLAL leads with 14.79% vs 5.65% for FBT. On fees, HLAL is cheaper at 0.50% per year. On volatility, HLAL has been the lower-risk option at 5.63%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, HLAL has performed better with a 14.79% return vs 5.65%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
HLAL is cheaper with a 0.50% expense ratio, compared with 0.57% for FBT.
HLAL has the higher dividend yield at 0.46%, compared with 0.00% for FBT.
FBT is categorized as Health & Biotech Equities, while HLAL is Large Cap Growth Equities. FBT tracks NYSE Arca Biotechnology Index, while HLAL tracks FTSE Shariah USA Index. They also come from different issuers: First Trust and Wahed. Their fees differ too: 0.57% for FBT and 0.50% for HLAL.
HLAL currently has the higher Sharpe Ratio (2.57 vs 1.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FBT and HLAL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer